Tennessee HB 1239: Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

Status: Pub. Ch. 295 (as of 2025-04-28)

State: Tennessee · Session: 114 · Bill: HB 1239

Subjects: Opioids

Sponsors: Helton-Haynes

View Tennessee HB 1239 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.